Interleukin-1 beta production in dysthymia before and after pharmacotherapy (Q73331958)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10624546%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Interleukin-1 beta production in dysthymia before and after pharmacotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10624546%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

H Anisman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10624546%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A V Ravindran

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10624546%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

J Griffiths

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10624546%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Z Merali

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10624546%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 December 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10624546%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

published in

Biological Psychiatry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10624546%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10624546%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10624546%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

1649-1655

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10624546%20AND%20SRC:MED&resulttype=core&format=json

Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

Depression, immunocompetence, and prostaglandins of the E series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

Neopterin measurement provides evidence of altered cell-mediated immunity in patients with depression, but not with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

Psychiatric implications of basic and clinical studies with corticotropin-releasing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

Development of a Rating Scale for Primary Depressive Illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

Biological studies of dysthymia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

Elevated levels of prostaglandin E2 and thromboxane B2 in depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

Evidence for an immune response in major depression: a review and hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

Significantly increased expression of T-cell activation markers (interleukin-2 and HLA-DR) in depression: Further evidence for an inflamatory process during that illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

Increased serum interleukin-1-receptor-antagonist concentrations in major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

A New Depression Scale Designed to be Sensitive to Change

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

Increased soluble interleukin-2 receptor concentrations in suicide attempters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: clinical symptoms and functional impairments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

Lymphocyte subsets associated with major depression and dysthymia: modification by antidepressant treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

Primary dysthymia: a study of several psychosocial, endocrine and immune correlates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

Cytokine production and serum proteins in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

Indicators of immune activation in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

The role of psychosocial and biological variables in separating chronic and non-chronic major depression and early-late-onset dysthymia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

Interleukin-1-induced plasticity of hypothalamic CRH neurons and long-term stress hyperresponsiveness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900211-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(99)00211-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10624546%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference